TACTful Perseverance and a Black Swan Event Tactful Perseverance and a Black Swan Event
–TACT2 to follow-up on post-MI diabetic patients.
“I have to admit that until 1999, I had no particular interest in studying a pariah therapy called EDTA chelation — really just not my style.”
“When the Duke staff distributed the previously blinded analyses, all of us turned to the bottom line, ... more
Free download: TACT2 overview with Dr. Gervasio Lamas Learn about the Trial to Assess Chelation Therapy 2 (TACT2) in this free presentation from the study chairman, Dr. Gervasio Lamas. Audio included.
more New study could help decide whether chelation benefits the heart Chelation therapy has long been scorned by many in the medical community. But after a major study suggested it was somewhat effective for heart disease, the alternative health treatment is ... more US deaths from lead exposure 10 times higher than thought, study suggests Lead exposure may be responsible for nearly 10 times more deaths in the United States than previously thought, according to a new study from The Lancet Public Health.
Watch the video ... more What is chelation, and how does it work? Dr. Jeff Baker, of Clinical Research Prime in Idaho Falls, Idaho, explains how removing toxic metals from the body with chelation therapy could help patients with cardiovascular issues. His clinic ... more Free info session on diabetes, heart disease, and TACT2 TACT2 investigator Dr. Richard Nahas will present a free information session on diabetes, heart disease, and the TACT2 study on Tuesday, February 13, 7:00–8:30 p.m., at Ben Franklin Place in ... more Nueva investigación sobre diabetes mira hacia el pasado Los diabéticos Tipo 2 con historial de paro cardíaco pueden encontrar una solución a sus complicaciones. ¿La clave? Una droga desarrollada en la década de 1950.
more To treat diabetes in new ways, TACT2 investigators look to the past Type 2 diabetics with a history of cardiac arrest might find a solution to their complications. The key? A drug developed in the 1950s.
more Chelation therapy: As good as statins, aspirin for your heart? Tact2 investigator Dr. Gervasio Lamas explains how chelation therapy could be a “game changer” in the treatment and prevention of heart disease.
more Little Rock Arkansas: The Arkansas Heart Hospital is participating in TACT2 March 28, 2017
Little Rock, Arkansas: The Arkansas Heart Hospital is now involved in a clinical trial that could lead to a new way to treat heart disease. Jancey Sheets has ... more MARQUETTE, MI: Local doctor takes part in in multinational therapy trial March 20, 2017
MARQUETTE, Mich. (WLUC) – An area doctor, right in Marquette, is part of a multinational therapy trial. This is the second stage of the trial to assess ... more Treatment might help prevent second heart attack for people with diabetes
GLENS FALLS – Chelation therapy is getting a close look as a way to prevent a second heart attack in people with diabetes. One of the study sites is in ... more Chelation, A Potentially Lifesaving Therapy Listen to the Intelligent Medicine podcast with Dr. Ronald Hoffman and hear TACT2 investigator Dr. Dana Cohen describe the TACT2 trial, a multi-million dollar government-sponsored study to evaluate the effectiveness ... more Chelation therapy: Life-saving alternative treatment? Read the story on the WPVI-TV Action News 11 Philadelphia, PA website. Includes an interview with Dr. Allan Magaziner in Cherry Hill, New Jersey, a TACT2 investigator.
more For daring to study a discredited therapy, this doctor earned scorn — and a $37 million grant Visit STAT to read the background of TACT and TACT2, and how Dr. Lamas has risked his reputation to bring the rigors of clinical research to what some considered quackery.
more Remover los metales tóxicos de la sangre ayuda a los diabéticos http://www.elnuevoherald.com/vivir-mejor/salud/article116993768.html
more Removing toxic metals from the blood — like lead — might help diabetes patients Read the news article in the November 23, 2016 Miami Herald.
more Ensayo clínico busca beneficios en pacientes diabéticos 9/29/2016 – The National Center for Complementary and Integrative Health (NCCIH) que forma parte de los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) ha otorgado $37M a ... more